Related Experiment Video
Updated: Mar 9, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Ligands of Therapeutic Utility for the Liver X Receptors
Rajesh Komati1, Dominick Spadoni2, Shilong Zheng3
1Department of Chemistry and RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA 70125, USA. rkomati@xula.edu.
Abstract:
Liver X receptors (LXRs) have been increasingly recognized as a potential therapeutic target to treat pathological conditions ranging from vascular and metabolic diseases, neurological degeneration, to cancers that are driven by lipid metabolism. Amidst intensifying efforts to discover ligands that act through LXRs to achieve the sought-after pharmacological outcomes, several lead compounds are already being tested in clinical trials for a variety of disease interventions. While more potent and selective LXR ligands continue to emerge from screening of small molecule libraries, rational design, and empirical medicinal chemistry approaches, challenges remain in minimizing undesirable effects of LXR activation on lipid metabolism. This review provides a summary of known endogenous, naturally occurring, and synthetic ligands. The review also offers considerations from a molecular modeling perspective with which to design more specific LXRβ ligands based on the interaction energies of ligands and the important amino acid residues in the LXRβ ligand binding domain.
Insights
Liver X receptors (LXRs) are key targets for diseases linked to lipid metabolism. This review summarizes LXR ligands and proposes molecular modeling for designing specific LXRβ ligands to minimize side effects.
Area of Science:
- Biochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Liver X receptors (LXRs) are crucial regulators of lipid metabolism.
- Dysregulated lipid metabolism is implicated in various diseases, including metabolic disorders, neurological conditions, and cancers.
- LXRs are recognized as promising therapeutic targets for these pathologies.
Purpose of the Study:
- To review endogenous, natural, and synthetic ligands targeting Liver X receptors (LXRs).
- To explore molecular modeling strategies for designing more specific LXRβ ligands.
- To address challenges in minimizing undesirable lipid metabolism effects associated with LXR activation.
Main Methods:
- Literature review of known LXR ligands.
- Analysis of ligand-protein interactions using molecular modeling.
- Examination of amino acid residue interactions within the LXRβ ligand-binding domain.
Main Results:
- Identification and categorization of diverse LXR ligands.
- Insights into the molecular basis of ligand binding to LXRβ.
- Considerations for structure-based drug design of selective LXR modulators.
Conclusions:
- LXRs represent a significant therapeutic avenue for a range of diseases.
- Developing selective LXRβ ligands through rational design is crucial for optimizing therapeutic outcomes.
- Molecular modeling offers a valuable approach to enhance ligand specificity and reduce off-target effects.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Signal Transduction: Overview
Typically, signal transduction involves three...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

